Rule Change Frees Unapproved Tests To Play Bigger Role In Emergencies
This article was originally published in The Gray Sheet
Executive Summary
FDA is amending its regulations to make it easier for a physician to test a patient for possible exposure to a terrorism-based or other infectious disease agent with an unapproved diagnostic without prior informed consent
You may also be interested in...
Regulatory News In Brief
Human factors guidance
Regulatory News In Brief
Human factors guidance
Device Companies Awaiting Feedback On Pandemic Stockpile Demand
Some medical device firms are holding out for more specific guidance from the federal government about pandemic flu planning before making firm production plans with products that could play a role in emergency preparedness